USP Improves, Expands Standards Related to Microbial Contamination and Bioburden Control - A Preview of USP's Upcoming Workshop on Microbiological Control of Compendial Articles

摘要

While many contributing factors can play a role in affecting the quality of a medicine or its ingredients, microbial contamination control and issues related to sterilization must always be major considerations for any manufacturer. For both sterile and non-sterile pharmaceutical products, manufacturing processes must minimize potential risk to the patient and the product. On July 23-24, 2012, the U.S. Pharmacopeial Convention (USP) will be hosting a workshop entitled, "Microbiological Control of Compendial Articles," which will take place at USP's headquarters in Rockviile, Md. Focusing on topics relevant to microbiological contamination and bioburden control, the workshop will highlight current and proposed USP public standards that help to ensure consistent quality in drug products and substances; dosage forms; and excipients.